Evidence map›Paper›PMID 29040612›Full record

ArticleJournal of molecular cell biology2017

ER stress-induced aggresome trafficking of HtrA1 protects against proteotoxicity.

Maximilian J Gerhardt, Joseph A Marsh, Margaux Morrison, Andrius Kazlauskas, Arogya Khadka, Stephan Rosenkranz, Margaret M DeAngelis, Magali Saint-Geniez, Sarah Melissa P Jacobo

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of molecular cell biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Maximilian J GerhardtDepartment of Ophthalmology, Harvard Medical School, The Schepens Eye Research Institute and Massachusetts Eye and Ear Infirmary, Boston, MA 02114, USA.
Joseph A MarshMRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK.
Margaux MorrisonDepartment of Ophthalmology and Visual Sciences, University of Utah and John A. Moran Eye Center, Salt Lake City, UT 84132, USA.
Andrius KazlauskasDepartment of Ophthalmology, Harvard Medical School, The Schepens Eye Research Institute and Massachusetts Eye and Ear Infirmary, Boston, MA 02114, USA.
Arogya KhadkaDepartment of Ophthalmology, Harvard Medical School, The Schepens Eye Research Institute and Massachusetts Eye and Ear Infirmary, Boston, MA 02114, USA.
Stephan RosenkranzDepartment III of Internal Medicine, Cologne University Heart Center, Center for Molecular Medicine, University of Cologne, 50931 Cologne, Germany.
Margaret M DeAngelisDepartment of Ophthalmology and Visual Sciences, University of Utah and John A. Moran Eye Center, Salt Lake City, UT 84132, USA.
Magali Saint-GeniezDepartment of Ophthalmology, Harvard Medical School, The Schepens Eye Research Institute and Massachusetts Eye and Ear Infirmary, Boston, MA 02114, USA.
Sarah Melissa P JacoboDepartment of Ophthalmology, Harvard Medical School, The Schepens Eye Research Institute and Massachusetts Eye and Ear Infirmary, Boston, MA 02114, USA.

Funding

Medical Research Council MR/M02122X/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID29040612
PMCPMC7485902

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.